Article
Metabolomics hallmarks OPA1 variants correlating with their in vitro phenotype and predicting clinical severity.
Human molecular genetics - 28 May 2020
Chao de la Barca Juan Manuel, Fogazza Mario, Rugolo Michela, Chupin Stéphanie, Del Dotto Valentina, Ghelli Anna Maria, Carelli Valerio, Simard Gilles, Procaccio Vincent, Bonneau Dominique, Lenaers Guy, Reynier Pascal, Zanna Claudia
Abstract excerpt
Interpretation of variants of uncertain significance is an actual major challenge. We addressed this question on a set of OPA1 missense variants responsible for variable severity of neurological impairments. We used targeted metabolomics to explore the different signatures of OPA1 variants expressed in Opa1 deleted mouse embryonic fibroblasts (Opa1-/- MEFs), grown under selective conditions. Multivariate analyses...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
